Laura Anne Hatfield, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medicaid | 7 | 2024 | 2716 | 1.160 |
Why?
|
Cardiac Resynchronization Therapy Devices | 2 | 2018 | 124 | 1.120 |
Why?
|
Models, Statistical | 6 | 2021 | 5100 | 1.050 |
Why?
|
Football | 2 | 2020 | 460 | 0.970 |
Why?
|
Medicare | 14 | 2020 | 6532 | 0.960 |
Why?
|
Patient Protection and Affordable Care Act | 3 | 2024 | 1208 | 0.890 |
Why?
|
Defibrillators, Implantable | 6 | 2018 | 1440 | 0.850 |
Why?
|
Cost Savings | 9 | 2024 | 925 | 0.740 |
Why?
|
Athletic Injuries | 2 | 2020 | 1153 | 0.700 |
Why?
|
Medicare Part C | 3 | 2024 | 296 | 0.690 |
Why?
|
Prisons | 1 | 2021 | 160 | 0.690 |
Why?
|
Diagnostic Self Evaluation | 1 | 2020 | 230 | 0.660 |
Why?
|
Brain Concussion | 2 | 2020 | 1318 | 0.650 |
Why?
|
Athletes | 3 | 2020 | 1092 | 0.650 |
Why?
|
Self Report | 4 | 2020 | 3548 | 0.630 |
Why?
|
Electric Countershock | 2 | 2018 | 535 | 0.630 |
Why?
|
Health Expenditures | 8 | 2019 | 2346 | 0.620 |
Why?
|
Sports Medicine | 1 | 2020 | 225 | 0.610 |
Why?
|
Epidemiologic Studies | 1 | 2021 | 676 | 0.610 |
Why?
|
Home Care Services | 2 | 2021 | 602 | 0.590 |
Why?
|
Diagnosis-Related Groups | 1 | 2019 | 454 | 0.590 |
Why?
|
Sturge-Weber Syndrome | 6 | 2007 | 91 | 0.580 |
Why?
|
Risk Management | 1 | 2020 | 571 | 0.560 |
Why?
|
Independent Living | 1 | 2020 | 564 | 0.560 |
Why?
|
United States | 36 | 2024 | 69693 | 0.520 |
Why?
|
Prenatal Care | 1 | 2022 | 1088 | 0.520 |
Why?
|
Etoposide | 1 | 2016 | 637 | 0.500 |
Why?
|
Pancreatectomy | 1 | 2019 | 802 | 0.500 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2019 | 744 | 0.480 |
Why?
|
Insurance, Health | 3 | 2022 | 2493 | 0.480 |
Why?
|
Research Design | 5 | 2022 | 5979 | 0.480 |
Why?
|
Prescription Drugs | 1 | 2021 | 595 | 0.480 |
Why?
|
Financing, Personal | 1 | 2016 | 308 | 0.480 |
Why?
|
Homosexuality, Male | 4 | 2010 | 1238 | 0.470 |
Why?
|
Triage | 1 | 2020 | 977 | 0.470 |
Why?
|
Hospitalization | 9 | 2023 | 10232 | 0.460 |
Why?
|
Unsafe Sex | 3 | 2010 | 220 | 0.450 |
Why?
|
Carboplatin | 1 | 2016 | 799 | 0.450 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2018 | 532 | 0.430 |
Why?
|
Models, Economic | 1 | 2016 | 713 | 0.430 |
Why?
|
Medically Uninsured | 4 | 2022 | 852 | 0.420 |
Why?
|
Health Status | 4 | 2020 | 4030 | 0.420 |
Why?
|
Safety | 1 | 2017 | 1185 | 0.410 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2016 | 384 | 0.400 |
Why?
|
Introduced Species | 1 | 2011 | 10 | 0.400 |
Why?
|
Petromyzon | 1 | 2011 | 8 | 0.400 |
Why?
|
Bayes Theorem | 4 | 2019 | 2303 | 0.400 |
Why?
|
Hepatitis C | 1 | 2021 | 1582 | 0.380 |
Why?
|
Bacterial Infections | 1 | 2019 | 1389 | 0.380 |
Why?
|
Students | 1 | 2020 | 1647 | 0.380 |
Why?
|
Continuity of Patient Care | 2 | 2017 | 1048 | 0.380 |
Why?
|
Premature Birth | 1 | 2022 | 1713 | 0.370 |
Why?
|
Universities | 3 | 2020 | 953 | 0.370 |
Why?
|
Health Personnel | 1 | 2024 | 3210 | 0.370 |
Why?
|
Physicians, Primary Care | 4 | 2024 | 577 | 0.360 |
Why?
|
Caregivers | 2 | 2021 | 2074 | 0.360 |
Why?
|
Cisplatin | 1 | 2016 | 1637 | 0.360 |
Why?
|
Regression Analysis | 2 | 2019 | 6452 | 0.350 |
Why?
|
Patient Acceptance of Health Care | 2 | 2019 | 3014 | 0.330 |
Why?
|
Psychotherapy | 1 | 2018 | 1644 | 0.320 |
Why?
|
Commerce | 3 | 2019 | 591 | 0.320 |
Why?
|
Pesticides | 1 | 2011 | 287 | 0.320 |
Why?
|
Data Interpretation, Statistical | 1 | 2018 | 2714 | 0.310 |
Why?
|
Terminal Care | 2 | 2017 | 1688 | 0.310 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2011 | 839 | 0.300 |
Why?
|
Quality Assurance, Health Care | 1 | 2018 | 2211 | 0.300 |
Why?
|
HIV Seropositivity | 2 | 2009 | 970 | 0.280 |
Why?
|
Heart Failure | 4 | 2018 | 10856 | 0.280 |
Why?
|
Humans | 69 | 2024 | 742088 | 0.270 |
Why?
|
Antidepressive Agents | 1 | 2018 | 2838 | 0.260 |
Why?
|
Preventive Health Services | 1 | 2010 | 575 | 0.250 |
Why?
|
Emergency Service, Hospital | 2 | 2022 | 7645 | 0.250 |
Why?
|
Cost Sharing | 2 | 2020 | 407 | 0.250 |
Why?
|
Models, Theoretical | 1 | 2017 | 3584 | 0.250 |
Why?
|
Hospitalists | 2 | 2020 | 304 | 0.250 |
Why?
|
Insurance Coverage | 3 | 2022 | 1895 | 0.240 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2010 | 2231 | 0.240 |
Why?
|
Drug Utilization Review | 2 | 2020 | 245 | 0.230 |
Why?
|
Telemedicine | 1 | 2020 | 2853 | 0.230 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3151 | 0.230 |
Why?
|
Fee-for-Service Plans | 2 | 2018 | 694 | 0.220 |
Why?
|
Decision Making | 1 | 2017 | 3869 | 0.220 |
Why?
|
Quality of Health Care | 3 | 2017 | 4369 | 0.210 |
Why?
|
Male | 41 | 2024 | 349538 | 0.210 |
Why?
|
Lung Neoplasms | 2 | 2017 | 13019 | 0.210 |
Why?
|
Length of Stay | 6 | 2023 | 6294 | 0.200 |
Why?
|
Computer Simulation | 3 | 2021 | 6191 | 0.200 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7153 | 0.190 |
Why?
|
Urban Population | 1 | 2009 | 2018 | 0.190 |
Why?
|
Aged | 24 | 2024 | 162944 | 0.190 |
Why?
|
Health Behavior | 2 | 2010 | 2630 | 0.190 |
Why?
|
Crowding | 1 | 2022 | 145 | 0.190 |
Why?
|
Disclosure | 2 | 2017 | 736 | 0.190 |
Why?
|
Personnel Management | 1 | 2020 | 55 | 0.180 |
Why?
|
Longitudinal Studies | 2 | 2018 | 13921 | 0.180 |
Why?
|
Health Care Costs | 4 | 2017 | 3203 | 0.180 |
Why?
|
Female | 36 | 2024 | 379592 | 0.180 |
Why?
|
Functional Laterality | 1 | 2007 | 2290 | 0.180 |
Why?
|
Product Surveillance, Postmarketing | 2 | 2015 | 430 | 0.170 |
Why?
|
Economics, Hospital | 2 | 2018 | 213 | 0.170 |
Why?
|
Infant, Low Birth Weight | 1 | 2022 | 850 | 0.160 |
Why?
|
Depression | 1 | 2018 | 7733 | 0.160 |
Why?
|
Referral and Consultation | 3 | 2020 | 3527 | 0.160 |
Why?
|
United States Food and Drug Administration | 3 | 2017 | 1581 | 0.160 |
Why?
|
Financial Management, Hospital | 1 | 2018 | 74 | 0.150 |
Why?
|
Myocardial Infarction | 3 | 2024 | 11690 | 0.150 |
Why?
|
Postoperative Complications | 1 | 2019 | 15244 | 0.150 |
Why?
|
Benchmarking | 1 | 2023 | 1038 | 0.140 |
Why?
|
Models, Organizational | 1 | 2020 | 574 | 0.140 |
Why?
|
General Practitioners | 1 | 2017 | 103 | 0.140 |
Why?
|
Insurance Claim Review | 2 | 2020 | 720 | 0.140 |
Why?
|
Hospitals, Rural | 1 | 2018 | 172 | 0.140 |
Why?
|
Budgets | 1 | 2018 | 227 | 0.140 |
Why?
|
Pancreatitis, Chronic | 1 | 2019 | 285 | 0.140 |
Why?
|
Treatment Outcome | 11 | 2024 | 62966 | 0.140 |
Why?
|
Developed Countries | 3 | 2024 | 436 | 0.140 |
Why?
|
Likelihood Functions | 1 | 2019 | 1003 | 0.140 |
Why?
|
Workload | 1 | 2022 | 849 | 0.130 |
Why?
|
Reimbursement Mechanisms | 2 | 2018 | 670 | 0.130 |
Why?
|
Fees and Charges | 1 | 2017 | 195 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11472 | 0.130 |
Why?
|
Hip Fractures | 1 | 2023 | 954 | 0.130 |
Why?
|
Delivery of Health Care | 5 | 2019 | 5304 | 0.130 |
Why?
|
SEER Program | 2 | 2017 | 1507 | 0.130 |
Why?
|
Arthroplasty, Replacement | 1 | 2019 | 336 | 0.120 |
Why?
|
Adolescent | 11 | 2020 | 85649 | 0.120 |
Why?
|
Transplantation, Autologous | 1 | 2019 | 2123 | 0.120 |
Why?
|
Access to Information | 1 | 2017 | 320 | 0.120 |
Why?
|
Epilepsy | 2 | 2007 | 3301 | 0.120 |
Why?
|
Psychotropic Drugs | 1 | 2019 | 893 | 0.110 |
Why?
|
Eligibility Determination | 1 | 2017 | 403 | 0.110 |
Why?
|
Health Benefit Plans, Employee | 1 | 2016 | 332 | 0.110 |
Why?
|
Cerebral Cortex | 2 | 2007 | 5705 | 0.110 |
Why?
|
Parturition | 1 | 2017 | 436 | 0.110 |
Why?
|
Linear Models | 2 | 2021 | 5948 | 0.110 |
Why?
|
Monte Carlo Method | 1 | 2018 | 1254 | 0.110 |
Why?
|
Aged, 80 and over | 9 | 2021 | 57683 | 0.110 |
Why?
|
Islets of Langerhans | 1 | 2019 | 1351 | 0.110 |
Why?
|
Abdominal Pain | 1 | 2019 | 1059 | 0.110 |
Why?
|
Substance-Related Disorders | 1 | 2009 | 4250 | 0.110 |
Why?
|
Time Factors | 5 | 2019 | 40054 | 0.110 |
Why?
|
Patient Selection | 2 | 2018 | 4214 | 0.110 |
Why?
|
Medical History Taking | 1 | 2016 | 783 | 0.110 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2023 | 1461 | 0.110 |
Why?
|
Biometry | 2 | 2016 | 558 | 0.100 |
Why?
|
Adult | 19 | 2022 | 213712 | 0.100 |
Why?
|
Consumer Product Safety | 1 | 2012 | 122 | 0.100 |
Why?
|
Equipment Safety | 1 | 2012 | 264 | 0.100 |
Why?
|
Reimbursement, Incentive | 1 | 2017 | 540 | 0.100 |
Why?
|
Electroencephalography | 1 | 2007 | 6142 | 0.100 |
Why?
|
Drug Utilization | 1 | 2018 | 1181 | 0.100 |
Why?
|
Patient Readmission | 2 | 2023 | 3111 | 0.100 |
Why?
|
Hospices | 1 | 2014 | 264 | 0.100 |
Why?
|
Meta-Analysis as Topic | 1 | 2016 | 1342 | 0.100 |
Why?
|
Income | 2 | 2017 | 1904 | 0.100 |
Why?
|
Lower Extremity | 1 | 2019 | 1151 | 0.090 |
Why?
|
Data Collection | 1 | 2020 | 3339 | 0.090 |
Why?
|
Young Adult | 4 | 2020 | 56350 | 0.090 |
Why?
|
Acute Disease | 1 | 2021 | 7141 | 0.090 |
Why?
|
Toxicity Tests | 1 | 2011 | 121 | 0.090 |
Why?
|
Critical Care | 1 | 2023 | 2640 | 0.090 |
Why?
|
Physical Examination | 1 | 2016 | 1239 | 0.090 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 950 | 0.090 |
Why?
|
Guanine | 1 | 2011 | 274 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 9941 | 0.090 |
Why?
|
Glutamates | 1 | 2011 | 398 | 0.090 |
Why?
|
Hazardous Substances | 1 | 2011 | 149 | 0.090 |
Why?
|
Amyl Nitrite | 1 | 2009 | 9 | 0.090 |
Why?
|
Equipment and Supplies | 1 | 2012 | 281 | 0.090 |
Why?
|
Hospice Care | 1 | 2016 | 671 | 0.090 |
Why?
|
Disabled Persons | 1 | 2019 | 1209 | 0.090 |
Why?
|
Suicide, Attempted | 1 | 2018 | 1218 | 0.090 |
Why?
|
Cross-Sectional Studies | 8 | 2024 | 24913 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6534 | 0.090 |
Why?
|
Safe Sex | 1 | 2010 | 141 | 0.090 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1411 | 0.080 |
Why?
|
Self Administration | 1 | 2009 | 386 | 0.080 |
Why?
|
Hospitals | 2 | 2022 | 3937 | 0.080 |
Why?
|
Research Report | 1 | 2011 | 355 | 0.080 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2011 | 640 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1831 | 0.080 |
Why?
|
Maryland | 2 | 2018 | 276 | 0.080 |
Why?
|
Socioeconomic Factors | 2 | 2023 | 7770 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2019 | 3915 | 0.080 |
Why?
|
North America | 1 | 2011 | 1249 | 0.070 |
Why?
|
Self Disclosure | 1 | 2008 | 251 | 0.070 |
Why?
|
Aortic Valve Stenosis | 1 | 2019 | 1941 | 0.070 |
Why?
|
Self Medication | 1 | 2007 | 117 | 0.070 |
Why?
|
HIV Infections | 2 | 2010 | 16678 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1436 | 0.070 |
Why?
|
Residence Characteristics | 1 | 2016 | 2049 | 0.070 |
Why?
|
Inpatients | 1 | 2018 | 2495 | 0.070 |
Why?
|
Middle Aged | 14 | 2020 | 213127 | 0.070 |
Why?
|
Fourier Analysis | 1 | 2007 | 447 | 0.070 |
Why?
|
Family | 1 | 2016 | 3144 | 0.070 |
Why?
|
Logistic Models | 1 | 2020 | 13403 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8621 | 0.070 |
Why?
|
Diagnostic Imaging | 2 | 2017 | 3507 | 0.070 |
Why?
|
Mesothelioma | 1 | 2011 | 818 | 0.060 |
Why?
|
Retrospective Studies | 9 | 2023 | 77098 | 0.060 |
Why?
|
Seasons | 1 | 2011 | 1492 | 0.060 |
Why?
|
Models, Psychological | 1 | 2009 | 810 | 0.060 |
Why?
|
Pain | 1 | 2020 | 4961 | 0.060 |
Why?
|
Infant, Newborn | 2 | 2022 | 25575 | 0.060 |
Why?
|
California | 2 | 2019 | 1400 | 0.060 |
Why?
|
Poverty | 3 | 2023 | 2646 | 0.060 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2005 | 438 | 0.060 |
Why?
|
Sexual Partners | 1 | 2008 | 730 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3667 | 0.060 |
Why?
|
Databases, Factual | 1 | 2018 | 7716 | 0.060 |
Why?
|
Pandemics | 1 | 2023 | 8328 | 0.060 |
Why?
|
Pregnancy | 2 | 2022 | 29087 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2016 | 3215 | 0.060 |
Why?
|
Health Education | 1 | 2010 | 1053 | 0.060 |
Why?
|
Equipment Failure | 2 | 2015 | 579 | 0.050 |
Why?
|
Risk Factors | 5 | 2024 | 72145 | 0.050 |
Why?
|
Disease Progression | 2 | 2011 | 13256 | 0.050 |
Why?
|
Mental Health | 1 | 2016 | 2997 | 0.050 |
Why?
|
Mental Disorders | 2 | 2019 | 6587 | 0.050 |
Why?
|
Insurance Carriers | 1 | 2024 | 156 | 0.050 |
Why?
|
Incidence | 1 | 2020 | 20928 | 0.050 |
Why?
|
Child | 8 | 2018 | 77478 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9144 | 0.050 |
Why?
|
Ontario | 1 | 2022 | 381 | 0.050 |
Why?
|
Quality Improvement | 1 | 2016 | 3738 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2011 | 6891 | 0.050 |
Why?
|
Congenital Abnormalities | 1 | 2005 | 707 | 0.050 |
Why?
|
Cohort Studies | 3 | 2022 | 40450 | 0.050 |
Why?
|
Southeastern United States | 1 | 2020 | 95 | 0.040 |
Why?
|
Analgesia, Patient-Controlled | 1 | 2020 | 109 | 0.040 |
Why?
|
Severity of Illness Index | 4 | 2019 | 15530 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 23320 | 0.040 |
Why?
|
Monitoring, Physiologic | 1 | 2007 | 1737 | 0.040 |
Why?
|
Hospital Bed Capacity | 1 | 2020 | 213 | 0.040 |
Why?
|
Myocardial Revascularization | 1 | 2023 | 841 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10248 | 0.040 |
Why?
|
Child, Preschool | 7 | 2016 | 40955 | 0.040 |
Why?
|
Quality of Life | 1 | 2019 | 12730 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2014 | 4823 | 0.040 |
Why?
|
Health Promotion | 1 | 2010 | 2194 | 0.040 |
Why?
|
Headache | 1 | 2005 | 1219 | 0.040 |
Why?
|
Group Practice | 1 | 2018 | 149 | 0.040 |
Why?
|
Algorithms | 1 | 2018 | 13853 | 0.040 |
Why?
|
Ownership | 1 | 2020 | 331 | 0.040 |
Why?
|
Internationality | 1 | 2023 | 1002 | 0.040 |
Why?
|
Inservice Training | 1 | 2020 | 392 | 0.040 |
Why?
|
Electronic Health Records | 3 | 2020 | 4440 | 0.040 |
Why?
|
Blue Cross Blue Shield Insurance Plans | 1 | 2017 | 94 | 0.040 |
Why?
|
Community Health Centers | 1 | 2020 | 428 | 0.040 |
Why?
|
Endpoint Determination | 1 | 2019 | 600 | 0.030 |
Why?
|
Infant | 5 | 2016 | 35070 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2006 | 3760 | 0.030 |
Why?
|
Michigan | 1 | 2016 | 350 | 0.030 |
Why?
|
Neoplasms | 2 | 2016 | 21596 | 0.030 |
Why?
|
Specialization | 1 | 2020 | 777 | 0.030 |
Why?
|
Migraine Disorders | 1 | 2007 | 1620 | 0.030 |
Why?
|
Cost Control | 1 | 2016 | 624 | 0.030 |
Why?
|
Massachusetts | 2 | 2017 | 8662 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 2023 | 2281 | 0.030 |
Why?
|
Health Plan Implementation | 1 | 2016 | 351 | 0.030 |
Why?
|
Computer-Assisted Instruction | 1 | 2016 | 365 | 0.030 |
Why?
|
Unnecessary Procedures | 1 | 2016 | 431 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2015 | 867 | 0.030 |
Why?
|
Prevalence | 1 | 2009 | 15194 | 0.030 |
Why?
|
Office Visits | 1 | 2016 | 598 | 0.030 |
Why?
|
Information Services | 1 | 2012 | 244 | 0.020 |
Why?
|
Medical Order Entry Systems | 1 | 2017 | 544 | 0.020 |
Why?
|
Health Services Accessibility | 2 | 2020 | 5133 | 0.020 |
Why?
|
Brain Mapping | 1 | 2007 | 6669 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2017 | 1679 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2007 | 35342 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2016 | 968 | 0.020 |
Why?
|
Health Policy | 1 | 2022 | 2657 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 3510 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2924 | 0.020 |
Why?
|
Health Services Research | 1 | 2016 | 1834 | 0.020 |
Why?
|
Outpatients | 1 | 2016 | 1483 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2022 | 5310 | 0.020 |
Why?
|
Government Regulation | 1 | 2012 | 522 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3582 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2005 | 17400 | 0.020 |
Why?
|
Tryptamines | 1 | 2007 | 88 | 0.020 |
Why?
|
Mortality | 1 | 2017 | 2857 | 0.020 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2005 | 101 | 0.020 |
Why?
|
Patient Discharge | 1 | 2017 | 3300 | 0.020 |
Why?
|
Choline | 1 | 2006 | 487 | 0.020 |
Why?
|
Creatine | 1 | 2006 | 421 | 0.020 |
Why?
|
Truth Disclosure | 1 | 2008 | 435 | 0.020 |
Why?
|
Risk-Taking | 1 | 2010 | 986 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2006 | 574 | 0.010 |
Why?
|
Carbohydrates | 1 | 2005 | 391 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8297 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9846 | 0.010 |
Why?
|
Communication | 1 | 2016 | 3728 | 0.010 |
Why?
|
Software | 1 | 2016 | 4434 | 0.010 |
Why?
|
Program Evaluation | 1 | 2010 | 2485 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2014 | 3679 | 0.010 |
Why?
|
Mutation | 1 | 2005 | 29717 | 0.010 |
Why?
|
Atrophy | 1 | 2005 | 1576 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2006 | 2885 | 0.010 |
Why?
|
Child Behavior Disorders | 1 | 2005 | 807 | 0.010 |
Why?
|
Analgesics | 1 | 2007 | 1037 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2005 | 2422 | 0.010 |
Why?
|
Animals | 1 | 2011 | 168561 | 0.010 |
Why?
|
Age of Onset | 1 | 2005 | 3266 | 0.010 |
Why?
|
Pedigree | 1 | 2005 | 4646 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2005 | 4742 | 0.010 |
Why?
|
Cholesterol | 1 | 2005 | 2895 | 0.010 |
Why?
|
Anticonvulsants | 1 | 2005 | 1914 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 53187 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2005 | 4030 | 0.010 |
Why?
|
Comorbidity | 1 | 2005 | 10372 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2005 | 8925 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2010 | 39004 | 0.000 |
Why?
|